Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Kaken to Codevelop Novel Multi-Specific Antibody with Swiss Biotech
January 15, 2021
- Daiichi Sankyo’s DMD Therapy Shows Efficacy in Several Patients in PI/II
January 14, 2021
- Nichi-Iko Announces Yet Another Recall, 38 Products Added to Bring Total to 75
January 14, 2021
- EA Pharma/Kissei Prepping to File Ulcerative Colitis Drug on Positive Japan PIII
January 14, 2021
- More than 90% of Patients Will Visit Doctors as Planned despite Emergency Declared: Survey
January 14, 2021
- Astellas Launches Joint Research on Molecular-Targeted Radiotherapies with US Biopharma
January 14, 2021
- Taiho Licenses SHP2 Drug Discovery Program to US Merck
January 14, 2021
- Chugai Links Up with IBM to Go Digital in Manufacturing
January 14, 2021
- Sosei Pairs Up with UK’s AI-Powered Drug Discovery Firm
January 13, 2021
- Medipal to Take on Akalux Distribution in Japan, Rakuten’s Photoimmunotherapy
January 13, 2021
- Nobelpharma Launches China Subsidiary
January 13, 2021
- Health Damages Linked to Kobayashi Kako Issue Rise to 210
January 13, 2021
- SymBio’s Anticancer Agent Treakisym Now Available in RTD Formulation
January 13, 2021
- Kobayashi Kako Expected to Face Administrative Penalty This Fiscal Year, Biz Suspension Likely
January 12, 2021
- Drug Makers, Wholesalers Boost WFH as Japan Declares Second Emergency
January 12, 2021
- Takeda Rolls Out Early Training Program for Young Management Candidates
January 12, 2021
- Meiji’s Belumosudil Enters Japan PI Study for cGVHD
January 12, 2021
- Japan Ethical Drug Sales Down 6.1% in November: Crecon
January 12, 2021
- Keytruda Tops in 2020 Drug Ranking for 2 Years in Row; Sales of 3 Cancer Meds Exceed 100 Billion Yen
January 8, 2021
- Keytruda Best-Selling Drug in December: Encise
January 8, 2021
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…